Varonis Systems VRNS Gained 268 Can It Break 3103 20260519 ADP Private Payrolls Surpass Expectations in April Signaling Resilient Labor Market Kamada KMDA Declines 294 Amid Market Weakness 20260519 Zymeworks ZYME Jumps 209 on Strong Momentum 20260518 Bernstein Reaffirms Outperform Rating on Diamondback Energy as Oil Supply Concerns Intensify DR Horton DHI Q1 2026 Earnings Why the Beat Matters USCuba Relations at Crossroads Rubio Warns Peaceful Deal Unlikely as Trump Signals Potential Intervention Elon Musk Could Break Saudi Aramcos IPO Record With One Listing South East Water Faces Operational Strain as Demand Surges Amid Record Heat Wall Street Awaits GameStop Chairman Ryan Cohens Next Move After eBay Rejects Takeover Bid OpenAI Takes Early Lead in AI IPO Race as Confidential Filing Reports Emerge Bond Markets Suggest Inflation Lag as Warsh Prepares to Assume Fed Leadership The Escalating 8 Billion Long COVID Crisis Rising Costs Amidst Federal Retreat NetEase Stock Declines Following Q1 Earnings Beat Market Reacts to Mixed Signals ALAB Q1 2026 Earnings EPS Beats Estimates Revenue Not Disclosed BLMN Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency Skye Bioscience Q1 2026 Earnings WiderthanExpected Loss Highlights Pipeline Progress SCHL Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Response Cisco Systems CSCO Q1 2026 Earnings EPS Slightly Beats Estimates Amid Strong Operational Performance Mortgage Rates Show Mixed Movements as of May 24 2026 GO Q1 2026 Earnings Earnings Beat Surprises as Grocery Outlet Posts Strong Profit Performance CLLS Q1 2026 Earnings NarrowerThanExpected Loss as GeneEditing Pipeline Advances Sonic Automotive SAH Q1 2026 Earnings EPS Surprises to the Upside Shares Gain Ground Bel Fuse Inc BELFB Q1 2026 Earnings EPS Beats Estimates by 888 Despite Stock Decline Diversified Energy Company Q2 2024 Earnings Strong EPS Beat Despite Negative Market Reaction Neonode Q1 2026 Earnings EPS Misses Estimates Amid Limited Revenue Disclosure AGNCP Q1 2026 Earnings Preferred Shares Benefit as EPS Exceeds Estimates by 145 Cyclerion Therapeutics CYCN Q4 2025 Earnings Narrower Loss Surprises Analysts